Rosuvastatin Effect on Telomere-telomerase System in ACS

Status Active, not recruiting

Clinical Trial Summary

Coronary heart disease (CHD) is one of the diseases characterised by biological aging as one of the important risk factors in several epidemiological studies. The mean telomere length and telomerase activity serve as markers for the biological age at the cellular level, with shorter telomeres and lower telomerase activity defining the increased biological age. Telomere length and telomerase activity, therefore, correlates with the risk of CHD and atherosclerosis. A present study states that the treatment with a statin is associated with a reduction in the number of clinical events but only in individuals with increased risk based on their telomere length. This suggests a positive relationship of telomere and telomerase system with the treatment with statins in CHD patients.

Clinical Trial Description

Coronary heart disease (CHD) is identified as one of the diseases characterised by biological aging as one of the important risk factors in several epidemiological studies. Premature biological aging is distinct from chronological aging and may predispose the individual to myocardial infarction, atherosclerosis and CHD in particular. The mean telomere length and telomerase activity serve as markers for the biological age at the cellular level, with shorter telomeres and lower telomerase activity defining the increased biological age. Telomere length and telomerase activity, therefore, correlates with the risk of CHD and atherosclerosis. Statins serve as the drugs of obvious choice based on their well established efficacy and safety profiles for the treatment of CHD and associated atherosclerosis. A present clinical study states that the treatment with a statin is associated with a reduction in the number of clinical events but only in individuals with increased risk based on their telomere length. This suggests a positive relationship of telomere and telomerase system with the risk of CHD and, therefore, would help clinicians to categorise the patient populations based on their leucocyte telomere length for treatment with statins. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02299245
Study type	Interventional
Source	Sun Yat-sen University
Contact
Status	Active, not recruiting
Phase	Phase 4
Start date	October 2014
Completion date	November 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04638517` - The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis	Phase 2
Completed	`NCT02844478` - Stress-Busting Program and QoL, Bio-markers of Immunity/Stress and Cellular Aging	N/A
Completed	`NCT04763525` - Efficacy of Pythagorean Self-Awareness for Aging Biomarkers Improvement, in T2D Patients and Healthy Individuals.	N/A
Not yet recruiting	`NCT03710356` - Evaluating Efficacy and Safety of Danazol in Severe Hematologic or Pulmonary Disease Related to Telomeropathy	Phase 1/Phase 2
Recruiting	`NCT05508321` - Nasal Brushing for the Diagnosis and Understanding of Telomeropathies	N/A
Completed	`NCT03982589` - Telomere Length in Relation to Acute Stress Response in Critical Care Patients
Not yet recruiting	`NCT06430073` - Effect of Infections and Global DNA Methylation on Frailty Trajectories in Hospitalized Older Patients (INFRAGEN)
Not yet recruiting	`NCT05978921` - Physical Exercise in Patients With Schizophrenia	N/A
Terminated	`NCT05715372` - Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy	N/A
Active, not recruiting	`NCT03286699` - Lifestyle Change for Better Health	N/A
Not yet recruiting	`NCT05598359` - TA-65 and Aging Associated Microvascular Dysfunction	N/A
Recruiting	`NCT06056375` - Biological and Behavioral Outcomes of Community Nature Walks	Phase 1
Completed	`NCT02055456` - Nandrolone Decanoate in the Treatment of Telomeropathies	Phase 1/Phase 2
Recruiting	`NCT04211714` - Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure	Phase 1
Completed	`NCT03459053` - CBART: The Reduction of Psychological and Physiological Stress in Women Undergoing IVF	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.